In vivo characterization of rabbit anti-mouse thymocyte globulin: A surrogate for rabbit anti-human thymocyte globulin

Transplantation

Volumn 88, Issue 2, 2009, Pages 170-179

  Ruzek, Melanie C ^a   Neff, Kathleen S ^a   Luong, Michael ^a   Smith, Karen A ^a   Culm Merdek, Kerry ^a   Richards, Susan M ^a   Williams, John M ^a   Perricone, Michael ^a   Garman, Richard D ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

Antithymocyte globulin; Murine; T cell depletion; Thymoglobulin

Indexed keywords

RABBIT ANTIMOUSE THYMOCYTE GLOBULIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG CLEARANCE; DRUG HALF LIFE; DRUG MECHANISM; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; T CELL DEPLETION; THYMOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; RABBITS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 68249092187     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181abc061     Document Type: Article

References (45)

1. Beiras-Fernandez A, Thein E, Hammer C. Induction of immunosuppression with polyclonal antithymocyte globulins: An overview. Exp Clin Transplant 2003; 2: 79.
2. Bacigalupo A. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: Efficacy and side effects. Bone Marrow Transplant 2005; 35: 225.
3. Mueller TF. Thymoglobulin: An immunologic overview. Curr Opin Organ Transplant 2003; 8: 305.
4. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Tranplant 2005; 5: 465.
5. Muller TF, Grebe SO, Reckzeh B, et al. Short- and long-term effects of polyclonal antibodies. Transplant Proc 1999; 31: 12S.
6. Muller TF, Grebe SO, Neuman MC, et al. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 1997; 64: 1432.
7. Klaus G, Mostert K, Reckzeh B, et al. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion. Transplantation 2003; 76: 1719.
8. Penack O, Fischer L, Stroux A, et al. Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell transplantation. Bone Marrow Transplant 2008; 41: 377.
9. Penack O, Fischer L, Gentilini C, et al. The type of ATG matters - Natural killer cells are influenced differently by Thymoglobulin, Lymphoglobulin and ATG-Fresenius. Transpl Immunol 2007; 18: 85.
10. Zand MS, Vo T, Pellegrin T, et al. Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin. Blood 2006; 107: 2895.
11. Zand MS, Vo T, Huggins J, et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005; 79: 1507.
12. Ayuk FA, Atassi N, Schuch G, et al. Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia. Leuk Res 2008; 32: 1200.
13. Monti P, Allavena P, Di Carlo V, et al. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol 2003; 3: 189.
14. Preville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460.
15. Murali-Krishna K, Ahmed R. Cutting edge: Naive T cells masquerading as memory cells. J Immunol 2000; 165: 1733.
16. + T cells: Costimulatory requirements and role of memory formation. J Immunol 2001; 167: 3699.
17. Ruzek MC, Waire JS, Hopkins D, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood 2008; 111: 1726.
18. +-selected allogeneic hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 2005; 11: 609.
19. Simon G, Parker M, Ramiya V, et al. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes 2008; 57: 405.
20. Ghobrial RRM, Boublik M, Winn HJ, et al. In vivo use of monoclonal antibodies against murine T cell antigens. Clin Immunol Immunopathol 1989; 52: 486.
21. Le Gros GS, Prestidge RL, Watson JD. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes. Immunology 1983; 50: 537.
22. Bonnefoy-Berard N, Vincent C, Revillard JP. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 1991; 51: 669.
23. Bourdage JS, Hamlin DM. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation 1995; 59: 1194.
24. Rebellato LM, Gross U, Verbanac KM, et al. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation 1994; 57: 685.
25. Regan JF, Lyonnais C, Campbell K, et al. Total and active thymoglobulin levels: Effects of dose and sensitization on serum concentrations. Transpl Immunol 2001; 9: 29.
26. + regulatory T cells. J Am Soc Nephrol 2006; 17: 2844.
27. LaCorcia G, Swistak M, Lawendowski C, et al. Polyclonal rabbit antithymocyte globulin exhibits consistent immunosuppressive capabilities beyond cell depletion. Transplantation 2009; 87: 966.
28. + regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J Immunol 2006; 176: 4125.
29. Lan F, Zeng D, Higuchi M, et al. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: The role of CD1-reactive natural killing T cells. Biol Blood Marrow Transplant 2003; 9: 355.
30. Ogawa N, Minamimura K, Kodaka T, et al. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. J Autoimmun 2006; 26: 225.
31. Novitsky N, Davison GM, Hale G, et al. Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome. Transplantation 2002; 74: 1551.
32. Minamura K, Sato K, Yagita H, et al. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice. Am J Transplant 2008; 8: 761.
33. Kroemer A, Xiao X, Vu MD, et al. OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J Immunol 2007; 179: 5584.
34. Chace JH, Cowdery JS, Field EH. Effect of anti-CD4 on CD4 subsets. I. Anti-CD4 preferentially deletes resting, naïve CD4 cells and spares activated CD4 cells. J Immunol 1994; 152: 405.
35. Perruche S, Zhang P, Liu Y, et al. CD3-specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat Med 2008; 14: 528.
36. + T cells in mice. Transplantation 2008; 85: 1167.
37. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632.
38. Dutt S, Tseng D, Ermann J, et al. Naïve and memory T cells induce different types of graft-versus-host disease. J Immunol 2007; 179: 6547.
39. + T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2008; 111: 2476.
40. Kawai T, Wee SL, Bazin H, et al. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation 2000; 70: 368.
41. + T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "Natural suppressor" cells. J Immunol 2001; 167: 2087.
42. Liu YP, Li Z, Nador RG, et al. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: Role of natural killer T cells. Transplantation 2008; 85: 607.
43. Higuchi M, Zeng D, Shizuru J, et al. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J Immunol 2002; 169: 5564.
44. Mapara MY, Pelot M, Zhao G, et al. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance. Biol Blood Marrow Transplant 2001; 7: 646.
45. Nikolic B, Khan A, Sykes M. Induction of tolerance by mixed chimerism with nonmyeloablative host conditioning: The importance of overcoming intrathymic alloresistance. Biol Blood Marrow Transplant 2001; 7: 144.